Hydrogen-rich water exerts anti-tumor effects comparable to 5-fluorouracil in a colorectal cancer xenograft model.
Fereshteh Asgharzadeh, Alex Tarnava, Asma Mostafapour, Majid Khazaei, Tyler W LeBaron · World journal of gastrointestinal oncology · 2022
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In Balb/c mice, as shown in Figure 2, HRW treatment decreased MDA levels in tumor tissues compared to control ( P < 0.05) and 5-FU treatment ( P < 0.001). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in Balb/c mice. As shown in Figure 2, HRW treatment decreased MDA levels in tumor tissues compared to control ( P < 0.05) and 5-FU treatment ( P < 0.001).
What the Researchers Studied
The researchers studied Balb/c mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
When tumor volumes reached 80-100 mm 3 (-10 d), 24 mice bearing tumors were divided randomly into four groups ( n = 6 per group) and treated as follows: (1) The control group. (2) The 5-FU group received intraperitoneal injections of 5-FU (5 mg/kg) every other day; (3) The H₂ group received HRW both from drinking water and by delivering 200 μL of the solution via oral gavage; and (4) The combination group, H₂ (administered in same way as group three) combined with 5-FU (administered in the same way as group two). As shown in Figure 2, HRW treatment decreased MDA levels in tumor tissues compared to control ( P < 0.05) and 5-FU treatment ( P < 0.001). The authors concluded that administration of HRW, with or without 5-FU, may serve as a therapeutic for treating CRC. 5-fluorouracil (5-FU) is a widely used chemotherapy agent, and molecular hydrogen (H₂) has been recognized for its antioxidant and anti-inflammatory effects, with research also suggesting its potential anti-tumor effects.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was Balb/c mice. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water.
Limitations and Safety
Reported limitations: Limitations of this study include that the observation period during the study was only 14 d, with rates of survival and remission not examined.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.